Contact:  Joe Barbrie

EMED Technologies Corporation

Phone: (888) 550-6500

Extension 118

 

1264 Hawks, Flight Court

Suite 200

El Dorado Hills, CA 95762

www.emedtccom

emed technologies corp.

 

Press Release

EMED announces CE Mark and Canadian Medical Device License Approval

El Dorado Hills, May 1, 2012: EMED Technologies Corporation today announced the approval to market the companyÕs SCIg60 Infusion System in Europe and in Canada.

 

SCIg60ÐVersaRate™ Infusion System

 

The SCIg60 Infuser is a reusable constant pressure mechanical syringe pump controlled by a proprietary rate flow device.

The VersaRateTM flow controller is a disposable device offering the clinician and patient a way to adjust the flow rate with an easy-to-use dial eliminating complications associated with having multiple rate sets with limited flow rates.

 

 

 

The EMED SCIg60 Infusion System consists of a proprietary mechanical syringe pump used with a patent pending variable rate control device VersaRateª and its market leading family of Soft-Glideª SCIg Infusion Sets used to administer subcutaneous immunoglobulin in treating patients with Primary Immune Deficiency Disease.

We are very pleased with the response of the European and Canadian clinical experts about the simplicity of use of the EMED Infusion system. EMED has submitted the system for FDA clearance. The SCIg60 Infusion system enhances our leading position in the SCIg market worldwide. "We will continue to interact with opinion leaders, patients and clinicians to ensure that their needs are met", said Paul Lambert, CEO

Headquartered in El Dorado Hills, CA, EMED develops, manufactures and markets medical devices worldwide.